Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.05 -0.15 (-1.14%)
As of: Oct 22, 2026 · 11:22 AM EDT

Eloxx Pharmaceuticals (ELOX) EPS (Diluted) (2021 - 2026)

Updated

Eloxx Pharmaceuticals (ELOX) recorded EPS (Diluted) of -$0.66 in Q2 2026, compared with -$5.45 a year earlier.

Analysis

Eloxx Pharmaceuticals (ELOX) EPS (Diluted) (2021 - 2026) Analysis & Trends

On a TTM basis, Eloxx Pharmaceuticals' EPS (Diluted) came in at -$1.75 as of Jun 30, 2026; for FY2025, it was -$5.34.

  • Across earlier years, EPS (Diluted) came in at -$9.20 in FY2024, -$72.98 in FY2023, -$183.13 in FY2022 and -$419.65 in FY2021.
  • The Q2 2026 figure is the highest quarterly EPS (Diluted) in data going back to Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 7.94
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 2.27
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 2.04
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn -0.54
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 1.67
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn 1.60
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn 4.37
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn -8.44
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn -0.04
10 Eloxx Pharmaceuticals 88.60 Mn 14.92 Mn - -0.66
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.66
Mar 31, 2026 -0.86
Jun 30, 2025 -5.45
Mar 31, 2025 -4.94
Dec 31, 2023 -12.37
Sep 30, 2023 -14.38
Jun 30, 2023 -21.58
Mar 31, 2023 -31.63
Dec 31, 2022 -32.09
Sep 30, 2022 -38.12
Jun 30, 2022 -53.91
Mar 31, 2022 -59.00
Dec 31, 2021 -76.03
Sep 30, 2021 -1.26
Jun 30, 2021 -5.97
API Access

Eloxx Pharmaceuticals EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ELOX&period=max&api_key=YOUR_API_KEY